CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex secures agreement with R&D partner Nucro-Technics, page-6

  1. 559 Posts.
    lightbulb Created with Sketch. 8
    ED honestly mate. I have tried rationalizing with you even when I feel it is not even warranted as your not even a shareholder. your fast becoming that annoying fly

    sorry mate but really. The company in my eyes is moving forward and being transparent.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.